Sargent Investment Group’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.1K | Sell |
35,620
-6,180
| -15% | -$5.56K | ﹤0.01% | 234 |
|
|
2025
Q1 | $21.7K | Sell |
41,800
-22,400
| -35% | -$11.6K | ﹤0.01% | 231 |
|
|
2024
Q4 | $38.4K | Sell |
64,200
-16,040
| -20% | -$9.59K | 0.01% | 231 |
|
|
2024
Q3 | $284K | Buy |
80,240
+10,400
| +15% | +$36.8K | 0.05% | 171 |
|
|
2024
Q2 | $553K | Sell |
69,840
-2,370
| -3% | -$18.8K | 0.11% | 114 |
|
|
2024
Q1 | $978K | Sell |
72,210
-4,150
| -5% | -$56.2K | 0.21% | 82 |
|
|
2023
Q4 | $825K | Sell |
76,360
-2,100
| -3% | -$22.7K | 0.18% | 99 |
|
|
2023
Q3 | $510K | Hold |
78,460
| – | – | 0.12% | 115 |
|
|
2023
Q2 | $1.41M | Sell |
78,460
-6,580
| -8% | -$118K | 0.34% | 62 |
|
|
2023
Q1 | $2.08M | Sell |
85,040
-2,661
| -3% | -$65.2K | 0.55% | 44 |
|
|
2022
Q4 | $2.19M | Buy |
87,701
+3,554
| +4% | +$88.9K | 0.68% | 39 |
|
|
2022
Q3 | $2.9M | Buy |
84,147
+4,929
| +6% | +$170K | 0.9% | 31 |
|
|
2022
Q2 | $3.13M | Buy |
79,218
+6,338
| +9% | +$250K | 0.97% | 29 |
|
|
2022
Q1 | $2.93M | Buy |
72,880
+302
| +0.4% | +$12.1K | 0.74% | 34 |
|
|
2021
Q4 | $3.67M | Buy |
72,578
+7,678
| +12% | +$388K | 0.84% | 31 |
|
|
2021
Q3 | $4.22M | Buy |
64,900
+21,012
| +48% | +$1.37M | 1.02% | 30 |
|
|
2021
Q2 | $1.7M | Buy |
43,888
+3,708
| +9% | +$144K | 0.4% | 48 |
|
|
2021
Q1 | $2.11M | Buy |
40,180
+11,589
| +41% | +$608K | 0.56% | 41 |
|
|
2020
Q4 | $1.94M | Buy |
28,591
+13,141
| +85% | +$894K | 0.61% | 36 |
|
|
2020
Q3 | $592K | Buy |
15,450
+9,159
| +146% | +$351K | 0.22% | 87 |
|
|
2020
Q2 | $246K | Buy |
6,291
+2,450
| +64% | +$95.8K | 0.09% | 129 |
|
|
2020
Q1 | $115K | Buy |
3,841
+2,724
| +244% | +$81.6K | 0.05% | 133 |
|
|
2019
Q4 | $127K | Buy |
+1,117
| New | +$127K | 0.05% | 149 |
|